Landauer Inc

Landauer — Investor Presentation (May 2013)

19 slides from Landauer's investor presentation, May 8, 2013

  1. Slide 1: Landauer, Inc. Investor Presentation May 8, 2013

    LANDAUER, INC. Investor Presentation May 8, 2013

  2. Slide 2: Safe Harbor Statement

    2 Safe Harbor Statement Some of the information shared here (including, in particular, the section titled “Fiscal 2013 Outlook”) constitutes forward - looking statements that are based on assumptions and involve certain risks and uncertainties . These include the following, without limitation : assu

  3. Slide 3: Fiscal 2013 Second Quarter Highlights

    3  Consolidated revenue $37.1 million, $2.0 million below prior year: » Medical Products down $1.8 million due to lower S pherz volume and price » Medical Physics down due to less episodic services  Consolidated gross profit $20.0 million, $3.0 million below prior year: - Additional IT Platform de

  4. Slide 4: The Radiation Safety Continuum

    Therapeutic / Diagnostic Accessories Information Imaging Physics Therapy Physics Patient Monitoring Occupational Monitoring Consulting Integrated Radiation Safety Solution Existing Services with Penetration Opportunities (1) Complementary Adjacent Products / Services _____________________ (1) Averag

  5. Slide 5: Landauer Strategy Overview

    Value Creation Deliver Upside Growth 1. Optimize Core 2.Competitive Growth 3. Strategic Expansion Strategic Priorities Landauer Strategy Overview Strategic Expansion Optimize the Core Competitive Growth  New Management/ Structure • Chief Financial Officer Q1’12 • Radiation Measurement Segment Q3‘12

  6. Slide 6: Radiation Measurement Segment

    6 Radiation Measurement Segment Optimize the Core ▪ IT System Stabilization: Post Go - Live in Q4 FY2012 ▪ $4.4 million in expense in FY 2013 ▪ Over 8,500 customers now on new web enabled system; versus previously 3,000 customers on 3 - legacy mainframe systems Competitive Growth ▪ Group Purchasing

  7. Slide 7: New IT Platform Enhancement Expenses

    7 New IT Platform Enhancement Expenses  Depreciation / Steady State / Customer Service / Implementation / Stabilization expenses: ― Total FY 2013 vs. FY 2012 $ 4.4 million increased expense over prior year • Depreciation, additional $2.4 million » Split between COG’s ($1.4 million) and SG&A ($1.0 m

  8. Slide 8: LDR IT Evolution: 2006-2012

    8 LDR IT Evolution: 2006 - 2012 Applications (since 2007) Infrastructure (since 2007) • Customer Records - o ver 500M records migrated from IBM legacy system to new IT System platform • Data Center Co - location Strategy – implemented in FY12. Disaster Recovery / Risk Mitigation: total investment to

  9. Slide 9: Military and Emergency Response Market Opportunity

    Military and Emergency Response Market Opportunity  Expanding application of next generation technology to pursue global military and first responder radiation monitoring markets  The U.S. military has now issued orders in excess of $20 million to upgrade its tactical dosimetry capabilities, and d

  10. Slide 10: Network of Activities - Synchronization

    10 Network of Activities - Synchronization

  11. Slide 11: Medical Physics Segment

    11 Medical Physics Segment Optimize the Core ▪ Profitability Improvement Initiatives: personnel utilization / exiting low margin legacy contracts ▪ Operating Margin of 10 percent year - to - date vs. 6.7 percent full year FY2012 vs. operating income loss in FY2011 Competitive growth ▪ Group Purchasi

  12. Slide 12: Radiation Safety is becoming more complex

    Radiation Safety is becoming more complex Assessment Remediation Ongoing Execution Control & Monitor 12 Advanced imaging and treatment choices, healthcare consolidation and tougher regulations and standards are raising the bar for radiation safety

  13. Slide 13: Enterprise Radiation Safety Portal

    opes . oti About LANDAUER werifii Enterprise Radiation Safety Portal ContactUs “Medical ysis insights with impact oe Poser? LANDAUER veDicaL PVs | 13

  14. Slide 14: Medical Products Segment

    14 Medical Products Segment  Changing market dynamics  Reorganized Leadership and Sales personnel/ structure/ processes in the fiscal quarter » CEO – twenty years of medical device product development experience » V.P. Sales – ten years of medical device experience  Acquisition » Acquired the ass

  15. Slide 15: IZI Medical Products - Market Map

    15 IZI Medical Products - Market Map Spherz Radiation Therapy

  16. Slide 16: FY 2013 Outlook vs. FY 2012 Actual

    16 FY 2013 Outlook vs. FY 2012 Actual Non - Cash Stock Based Compensation Previous Revised Guidance Guidance – FY 2013 Forecast $3.3M $2.7M – FY 2012 Actual $2.4M – Delta $0.9M $0.3M

  17. Slide 17: Fiscal Year 2013 Outlook - Updated

    FY 2013 Outlook Updated 17 Fiscal Year 2013 Outlook - Updated ▪ Expected Revenue $ 150 to $ 155 million, which includes a full fiscal year of contributions from the IZI Medical Products acquisition, versus 10.5 months in fiscal 2012 ▪ Adjusted EBITDA of $51 to $ 53 million ▪ Net Income of $21 to $23

  18. Slide 18: Current Dividend Policy

    18 Current Dividend Policy Current Dividend Policy • Board of Directors declared a regular quarterly cash dividend of $0.55 per share for the f irst quarter of fiscal 2013 – This represents an annual rate of $2.20 per share, consistent with fiscal 2012 levels – For the first fiscal quarter, the divi

  19. Slide 19: Questions?

    Questions? Investor Presentation May 8, 2013

Landauer — Investor Presentation (May 2013) on 6ix